Is CAH or REGN cheaper?

On trailing earnings, REGN is cheaper: CAH trades at a 34.23 P/E and REGN at 14.92.

Which has grown faster, CAH or REGN?

Over the past five years, REGN grew revenue faster — CAH at a 9.86% CAGR versus REGN at 10.16%.

Does CAH or REGN pay a bigger dividend?

CAH yields 0.91% and REGN yields 0.59% based on trailing dividends and the latest price.

Is CAH or REGN more profitable?

REGN runs the higher net margin — CAH at 0.62% versus REGN at 29.65%.

Which has been the better investment, CAH or REGN?

Over the past 10-year, CAH delivered the higher annualized total return — CAH at 14.21% versus REGN at 5.19%. Past performance doesn't predict future results.

Cardinal Health, Inc. (CAH) vs Regeneron Pharmaceuticals, Inc. (REGN)

CAH and REGN are evenly matched — 8 metrics each of 16.

A side-by-side comparison of Cardinal Health, Inc. and Regeneron Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

CAH

Cardinal Health, Inc.

$52.43B

$223.85Healthcare

REGN

Regeneron Pharmaceuticals, Inc.

$63.06B

$612.14Healthcare

Total return — CAH vs REGN

growth of $100 · last 30y

CAH +910.6%REGN +3554.6%REGN compounded faster

CAH REGN

CAH vs REGN: by the numbers

•REGN is the larger company ($63.06B vs $52.43B market cap).
•REGN trades at the lower earnings multiple (14.92 vs 34.23 P/E).
•REGN converts more revenue to profit (29.65% vs 0.62% net margin).
•REGN grew revenue faster over the past five years (10.16% vs 9.86% CAGR).
•CAH pays the higher dividend yield (0.91% vs 0.59%).

Which is better, CAH or REGN?

Metric tally: CAH 8 · REGN 8

It depends on what you're optimizing for:

ValueREGN(lower P/E)

GrowthREGN(faster 5Y revenue CAGR)

IncomeCAH(higher dividend yield)

QualityCAH(higher ROIC)

Metrics side by side

Valuation

Metric	CAH	REGN
P/E ratio	34.23	14.92●
Forward P/E	18.64	11.30●
P/S ratio	0.21●	4.42
P/B ratio	—	2.10
PEG ratio	0.30●	3.38
EV / EBITDA	19.10	11.43●
FCF yield	8.31%●	6.30%

Profitability

Metric	CAH	REGN
Gross margin	3.68%	84.55%●
Operating margin	0.92%	24.32%●
Net margin	0.62%	29.65%●
ROE	-56.13%	14.08%●
ROIC	11.37%●	8.51%

Dividends

Metric	CAH	REGN
Dividend yield	0.91%●	0.59%
Payout ratio	31.52%	8.45%

Growth (annualized)

Metric	CAH	REGN
Revenue CAGR (5Y)	9.86%	10.16%●
EPS CAGR (5Y)	6.11%●	5.70%
FCF CAGR (5Y)	22.47%●	15.42%
Total return CAGR (5Y)	33.46%●	3.26%

Frequently asked

Which is better, CAH or REGN?: It depends on your goal. value: REGN (lower P/E); growth: REGN (faster 5Y revenue CAGR); income: CAH (higher dividend yield); quality: CAH (higher ROIC). Across all compared metrics, they are evenly matched.
Is CAH or REGN cheaper?: On trailing earnings, REGN is cheaper: CAH trades at a 34.23 P/E and REGN at 14.92.
Which has grown faster, CAH or REGN?: Over the past five years, REGN grew revenue faster — CAH at a 9.86% CAGR versus REGN at 10.16%.
Does CAH or REGN pay a bigger dividend?: CAH yields 0.91% and REGN yields 0.59% based on trailing dividends and the latest price.
Is CAH or REGN more profitable?: REGN runs the higher net margin — CAH at 0.62% versus REGN at 29.65%.
Which has been the better investment, CAH or REGN?: Over the past 10-year, CAH delivered the higher annualized total return — CAH at 14.21% versus REGN at 5.19%. Past performance doesn't predict future results.

Go deeper

Full CAH analysis Full REGN analysis Interactive comparison tool

Dig into the metrics

Cardinal Health P/E ratio Regeneron Pharmaceuticals P/E ratio Cardinal Health dividend yield Regeneron Pharmaceuticals dividend yield Cardinal Health ROE Regeneron Pharmaceuticals ROE Cardinal Health operating margin Regeneron Pharmaceuticals operating margin Cardinal Health revenue growth Regeneron Pharmaceuticals revenue growth Cardinal Health free cash flow Regeneron Pharmaceuticals free cash flow

Cardinal Health & Regeneron Pharmaceuticals appear in these rankings

Dividend Aristocrats Highest FCF Yield Stocks Best 10-Year Total Return Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 15, 2026.